Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactobacillus plantarum TCI507
- Development stage
- Unknown
- Lead developer
- TCI
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Lactobacillus plantarum TCI507 is a probiotic strain extracted from orange peels. It has been shown to have multiple health benefits including weight loss effects and cholesterol-lowering properties. The strain works as a microbiome modulator and has been verified through in vitro experiments to hydrolyze bile salts and inhibit fat cell production. Clinical studies have demonstrated that TCI507 can effectively reduce total cholesterol and low-density lipoprotein levels in human blood, promoting cardiovascular health. The strain was deposited at the Food Industry Development Research Institute on December 21, 2006, with the deposit number BCRC910806.
- Other names
- Lactobacillus plantarum TCI507BCRC910806BCRC-910806BCRC 910806
02
Targets
APOA1 (Apolipoprotein A-I)LDLR (Low-density lipoprotein receptor)SCARB1 (Scavenger receptor class B member 1)
Beyond the preview
Go deeper on Lactobacillus plantarum TCI507.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactobacillus plantarum TCI507.